Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane and coiled-coil domain-containing protein 4 (TMCO4) is a human protein encoded by the TMCO4 gene on chromosome 1p36.13. TMCO4 is a multipass transmembrane protein predicted to span the endoplasmic reticulum membrane three times[1][5][7]. While its precise cellular function remains unclear, it is classified as a protein of unknown function associated with the α/β hydrolase fold family and annotated as a trispanin (three transmembrane domains). TMCO4 is expressed in various tissues, localizes predominantly to the endoplasmic reticulum, and is postulated—based on protein-protein interaction data and tissue expression patterns—to participate in protein localization, targeting, or trafficking processes[1][4]. Some data suggest that it interacts with proteins known to be implicated in cancer development, though no direct evidence currently establishes it as a drug target or with a defined disease mechanism[1][7]. TMCO4 is not recognized as a current therapeutic target and has no validated disease biomarkers, drug interactions, or significant safety concerns reported at this time[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane and coiled-coil domain-containing protein 4 (TMCO4).